These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 9230200)
1. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Piazza GA; Alberts DS; Hixson LJ; Paranka NS; Li H; Finn T; Bogert C; Guillen JM; Brendel K; Gross PH; Sperl G; Ritchie J; Burt RW; Ellsworth L; Ahnen DJ; Pamukcu R Cancer Res; 1997 Jul; 57(14):2909-15. PubMed ID: 9230200 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354 [TBL] [Abstract][Full Text] [Related]
3. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Reddy BS; Rao CV; Seibert K Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets. Rao CV; Reddy BS; Steele VE; Wang CX; Liu X; Ouyang N; Patlolla JM; Simi B; Kopelovich L; Rigas B Mol Cancer Ther; 2006 Jun; 5(6):1530-8. PubMed ID: 16818512 [TBL] [Abstract][Full Text] [Related]
7. Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Samaha HS; Kelloff GJ; Steele V; Rao CV; Reddy BS Cancer Res; 1997 Apr; 57(7):1301-5. PubMed ID: 9102217 [TBL] [Abstract][Full Text] [Related]
8. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Rao CV; Rivenson A; Simi B; Reddy BS Cancer Res; 1995 Jan; 55(2):259-66. PubMed ID: 7812955 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate. Rao CV; Rivenson A; Simi B; Zang E; Hamid R; Kelloff GJ; Steele V; Reddy BS Cancer Res; 1995 Oct; 55(19):4311-8. PubMed ID: 7671241 [TBL] [Abstract][Full Text] [Related]
11. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859 [TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579 [TBL] [Abstract][Full Text] [Related]
13. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574 [TBL] [Abstract][Full Text] [Related]
14. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066 [TBL] [Abstract][Full Text] [Related]
15. Sulfone metabolite of sulindac inhibits mammary carcinogenesis. Thompson HJ; Jiang C; Lu J; Mehta RG; Piazza GA; Paranka NS; Pamukcu R; Ahnen DJ Cancer Res; 1997 Jan; 57(2):267-71. PubMed ID: 9000566 [TBL] [Abstract][Full Text] [Related]
16. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Kawamori T; Rao CV; Seibert K; Reddy BS Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081 [TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate. Rao CV; Desai D; Rivenson A; Simi B; Amin S; Reddy BS Cancer Res; 1995 Jun; 55(11):2310-5. PubMed ID: 7757981 [TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats. Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004 [TBL] [Abstract][Full Text] [Related]
19. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis. Reddy BS; Kawamori T; Lubet R; Steele V; Kelloff G; Rao CV Carcinogenesis; 1999 Aug; 20(8):1645-8. PubMed ID: 10426822 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]